Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ann Cardiol Angeiol (Paris) ; 67(2): 98-100, 2018 Apr.
Artículo en Francés | MEDLINE | ID: mdl-29602443

RESUMEN

Vitamin K antagonists (VKA) are difficult to use because of a narrow therapeutic index and of a marked inter- and intra-individual variability among patients in the required dosage. This drug may interact with many other drugs and same with certain food compounds. We report the case of potential interaction between soy lecithin and Vitamin K antagonists in a 46 years-old woman. Subtherapeutic INR values were detected despite the increase gradually in dose and replacing acenocoumarol by fluindione. An enquiry of pharmacovigilance was conducted found the consumption of soy lecithin capsules. Fifteen days after its stopping, the INR values have really increased. Clinicians should think to the possibility of interaction between oral anticoagulants and food supplement that is increasingly used.


Asunto(s)
Anticoagulantes/farmacología , Resistencia a Medicamentos , Glycine max , Lecitinas/farmacología , Tensoactivos/farmacología , Vitamina K/antagonistas & inhibidores , Vitamina K/farmacología , Administración Oral , Anticoagulantes/administración & dosificación , Femenino , Interacciones Alimento-Droga , Humanos , Relación Normalizada Internacional , Lecitinas/administración & dosificación , Persona de Mediana Edad , Tensoactivos/administración & dosificación
2.
Eur Rev Med Pharmacol Sci ; 19(12): 2301-2, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26166659

RESUMEN

We report the case of a 52-year-old man with type 2 diabetes, who developed severe mucosal erosions of the tongue, glans penis and perianal area, induced by glimepiride. A tissue biopsy was performed and revealed the characteristics of lichen planus (LP). The improvement of the patient's condition after withdrawal of glimepiride added to recurrence of the lesions when medication was reintroduced confirmed that the second generation anti-diabetic was the causative agent. To the best of our knowledge, this has not been reported previously.


Asunto(s)
Hipoglucemiantes/efectos adversos , Erupciones Liquenoides/inducido químicamente , Erupciones Liquenoides/diagnóstico , Compuestos de Sulfonilurea/efectos adversos , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Erupciones por Medicamentos/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Lengua/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA